INTERFERENCE WITH POSTTRANSLATIONAL MODIFICATION OF LYSINES MODIFIES STABILITY OF F508DEL CFTR

被引:0
|
作者
Lee, S. [1 ]
Odeh, H. M. [2 ]
Matunis, M. J. [2 ]
Zeitlin, P. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA
[2] Johns Hopkins Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
68
引用
收藏
页码:218 / 218
页数:1
相关论文
共 50 条
  • [31] ELECTROCHEMICAL MEMBRANE CHOLESTEROL MEASUREMENT AS A BIOMARKER FOR PHARMACOLOGICAL F508DEL CFTR CORRECTION
    Lu, B.
    Corey, D.
    Hodges, C. A.
    Cotton, C.
    Kelley, T.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S362 - S362
  • [32] The novel CFTR haplotype E583G/F508del in CFTR-related disorder
    De Paolis, Elisa
    Tilocca, Bruno
    Inchingolo, Riccardo
    Lombardi, Carla
    Perrucci, Alessia
    Maneri, Giulia
    Roncada, Paola
    Varone, Francesco
    Luca, Richeldi
    Urbani, Andrea
    Minucci, Angelo
    Santonocito, Concetta
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [33] Calumenin contributes to ER-Ca2+ homeostasis in bronchial epithelial cells expressing WT and F508del mutated CFTR and to F508del-CFTR retention
    Philippe, Reginald
    Antigny, Fabrice
    Buscaglia, Paul
    Norez, Caroline
    Huguet, Florentin
    Castelbou, Cyril
    Trouve, Pascal
    Becq, Frederic
    Frieden, Maud
    Ferec, Claude
    Mignen, Olivier
    CELL CALCIUM, 2017, 62 : 47 - 59
  • [34] HSP27 LEADS TO SUMO-2/3 MODIFICATION OF F508DEL CFTR AND ITS DEGRADATION BY A STUBL
    Gong, X.
    Ahner, A.
    Schmidt, B.
    Rabeh, W.
    Lukacs, G.
    Frizzell, R. A.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 236 - 237
  • [35] CHANGE IN BURDEN OF ILLNESS IN CF PATIENTS HOMOZYGOUS FOR THE F508DEL CFTR GENE MUTATION
    Lubarsky, B.
    O'Sullivan, A.
    Millar, S.
    Pasta, D.
    Sawicki, G.
    Wagener, J.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 346 - 347
  • [36] CHANGES IN LCI IN F508DEL/F508DEL PATIENTS TREATED WITH LUMACAFTOR/IVACAFTOR: RESULTS FROM THE PROSPECT STUDY
    Ratjen, F.
    Klingel, M.
    Clancy, J. P.
    Sagel, S.
    Donaldson, S. H.
    Rowe, S. M.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S287 - S287
  • [37] EFFECTS OF LUMACAFTOR/IVACAFTOR IN CYSTIC FIBROSIS PATIENTS HOMOZYGOUS FOR F508DEL CFTR MUTATION
    Melotti, P.
    Tridello, G.
    Pintani, E.
    Meneghelli, I
    Volpi, S.
    Spinelli, E.
    D'Orazio, C.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 242 - 242
  • [38] F508DEL IMPAIRMENT OF NBD DIMERIZATION
    Chong, P.
    Hudson, R.
    Vernon, R. M.
    Forman-Kay, J.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 228 - 228
  • [39] LEAD IDENTIFICATION OF CFTR F508DEL CORRECTORS THROUGH A COMBINATION OF FUNCTIONAL AND MECHANISTIC ASSAYS
    Liang, F.
    Harrington, J.
    Layer, E.
    Valdez, R.
    Bhatt, P.
    Amarnani, D.
    Sui, J.
    Cole, B.
    Bihler, H.
    Mense, M.
    Fitzpatrick, R.
    PEDIATRIC PULMONOLOGY, 2011, : 278 - 279
  • [40] SEVERE BONE LOSS ASSOCIATED WITH REDUCED BONE FORMATION IN F508DEL CFTR MICE
    Le Henaff, C.
    Gimenez, A.
    Hay, E.
    Marty, C.
    Marie, P.
    Jacquot, J.
    PEDIATRIC PULMONOLOGY, 2010, : 293 - 293